After an industry-wide blitz promoting their use, testosterone medications, like AndroGel, have become cash cows for pharmaceutical companies. The drugs have gone from being prescribed to a narrow subset of men with hypogonadism to healthy men who happen to have low-testosterone levels. This rampant off-label prescription has left the FDA with the task of identifying the appropriate groups of men for whom testosterone use should be allowed. In advance of its September 17, 2014 hearing on this issue, the FDA issued its advisory reports for testosterone on September 3, 2014.
The FDA noted that "treatment benefits with [testosterone] for 'age-related hypogonadism' [also known as "Low-T"] remain questionable, and there are no reliable data on the benefit in such a population." Based on these findings, "the FDA has decided to reassess the appropriate patient population for [testosterone] and to ensure that the labeling for FDA-approved testosterone therapies appropriately refelcts the population for whom [testosterone] is indicated."
Not only do testosterone medications fail to deliver a benefit, they can also cause serious injuries. Recent studies have shown that testosterone can cause heart attacks, strokes, pulmonary emboli, blood clots and congestive heart failure.
If you or a loved one have suffered a heart attack, stroke, pulmonary embolism, blood clot or congestive heart failure while taking tesotsterone medications, like AndroGel, please call our experienced AndroGel attorneys at (888) 606-5297 for a free consultation about your potential AndroGel lawsuit.